SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,028.02 1,718.01
( 2.17%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

97.3802066

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

127.84

446276.3

EPS(TTM)

Face Value()

Div & Yield %

14.55

0.86

Back

vjil consulting ltd

Royal India Corporation consolidated net profit declines 39.13% in the June 2026 quarter

Aug 12,2026

Net profit of Royal India Corporation declined 39.13% to Rs 1.96 crore in the quarter ended June 2026 as against Rs 3.22 crore during the previous quarter ended June 2025. Sales declined 91.29% to Rs 3.63 crore in the quarter ended June 2026 as against Rs 41.67 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	3.63	41.67	-91
OPM %	26.72	8.54	-
PBDT	2.01	3.23	-38
PBT	1.93	3.22	-40
NP	1.96	3.22	-39

81,028.02 1,718.01 ( 2.17%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)